The primary endpoint is objective response rate, with progression-free survival a key secondary endpoint. The study includes a pre-registration step for arm determination by the molecular tumor board.
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...
A stoppage-time penalty by substitute Gustaf Nilsson secured Club Brugge a 2-1 home win against Atalanta in the first leg of ...
NYSE: EVTL], a global aerospace and technology company that is pioneering electric aviation, has successfully completed the ...
During Phase 2, the aircraft completed over thirty piloted ... as we prepare for our most advanced stage of testing yet. Simon Davies, Vertical’s Chief Test Pilot, who flew the VX4, said ...
Marks and Spencer boss Stuart Machin repeats call on government to phase in increase to employers’ national insurance ...
Gustaf Nilsson wins and scores a controversial late penalty as Club Brugge claim a narrow lead over Atalanta in the first leg of their Champions League knockout play-off tie.
Dr. Gunn added, “Given QBECO SSI’s novel immunological mechanism and the growing interest in the role of senescence in the progression of aging and chronic disease, these data suggest that clearing ...
Here is all you need to know about the Paarl Royals vs Sunrisers Eastern Cape playoff game in SA20: preview, squads, telecast ...
Atalanta were left furious and incredulous after a ridiculous stoppage-time penalty decision sealed Club Brugge’s 2-1 first ...
The Company’s Board of Directors have approved the grant of incentive stock options to directors, officers, employees and consultants to purchase up to an aggregate of 3,430,00 common shares in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results